The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine
Open accessAbstract
Microdialysis in behaving animals was used to concomitantly characterize the dopamine and 5-HT responses in the caudate and the norepinephrine response in the hippocampus to the D- and L-isomers of amphetamine and methamphetamine. Doses of all four drugs which promoted similar stereotypy responses produced a D-amphetamine-like response profile of dopamine and dopamine metabolites, suggesting that all these drugs interact with dopamine systems to facilitate the release of transmitter. However, in contrast to the similar behavioral profiles, the magnitude of the dopamine responses diverged significantly. In addition, all four drugs increased extracellular norepinephrine and 5-HT, but the relative responses differed markedly from dopamine and from each other. The contrasting structure-activity relationships for these drugs likely reflect their differential potency at the various neuronal uptake transporters in promoting either transmitter release, and/or uptake blockade. In addition, the interaction of each drug at the vesicular transporters, as well as the availability of a cytoplasmic pool of transmitter likely also contribute to the neurotransmitter response. Because of the particularly divergent transmitter response profiles exhibited by L-methamphetamine, its behavioral and neurotransmitter effects were characterized over a more extended range of doses. Although the duration of the increase in extracellular dopamine was clearly proportional to dose, the dose-dependent increases in the magnitude of the dopamine response did not parallel the behavioral profiles. The results of these studies indicate that, while the dopamine, norepinephrine and 5-HT responses to these drugs probably contribute to the expression of stimulant-induced behaviors, simple relationships between the neurotransmitter responses and the behavioral profiles were not evident.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AMP increases the synaptic levels of monoamines (dopamine, noradrenaline and serotonin) by increasing their release through a reversal of the monoamine transporters, primarily the catecholamine transporters (see Fleckenstein et al., 2007; Hutson et al., 2014, for review; Kuczenski et al., 1995; Sulzer et al., 2005).”
From Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits (2023) · cites this paper as Kuczenski et al., 1995
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zetterström, T., Sharp, T., Marsden, C. A., & Ungerstedt, U. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00893.x · Cited by 616
Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model.
Fischer, J. F., & Cho, A. K. (1979) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31549-1 · Cited by 443
Self-citationDetermination of Brain Interstitial Concentrations by Microdialysis
Benveniste, H., Hansen, A. J., & Ottosen, N. S. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07252.x · Cited by 403
Kuczenski, R. T., & Segal, D. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-06-02051.1989 · Cited by 398
Self-citationSulzer, D., & Rayport, S. (1990) · Neuron · doi:10.1016/0896-6273(90)90339-h · Cited by 389
Heikkila, R. E., Orlansky, H., Mytilineou, C., & Cohen, G. (1975) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30227-2 · Cited by 220
Berger, U. V., Gu, X. F., & Azmitia, E. C. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90023-w · Cited by 199
Segal, D. S., & Kuczenski, R. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39192-5 · Cited by 177
Self-citationSampling considerations for on-line microbore liquid chromatography of brain dialysate
Wages, S. A., Church, W. H., & Justice, J. B. (1986) · Analytical Chemistry · doi:10.1021/ac00121a012 · Cited by 172
Globus, M. Y. ‐., Busto, R., Dietrich, W. D., Martinez, E., Valdés, I., & Ginsberg, M. D. (1989) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1989.123 · Cited by 165
Research works printed but not linked: 1
- Cole SO (1978) Brain mechanisms ofamohetamine-induced anorexia. locomdtion, And stereotypy: a review. fieurosci Biobehav Rev 2:891 100.
Cited by
Sorted by citations
Items 201–300 of 376
Behavioral alterations induced by an escalating dose-binge pattern of cocaine administration
Segal, D. S., & Kuczenski, R. T. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00067-3 · Cited by 25
Self-citationWiig, K. A., Whitlock, J. R., Epstein, M. H., Carpenter, R. L., & Bear, M. F. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.02.001 · Cited by 24
Kaushal, N., Seminerio, M. J., Robson, M. J., McCurdy, C. R., & Matsumoto, R. R. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.08.005 · Cited by 24
Doyle, J. R., & Yamamoto, B. K. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.10.001 · Cited by 24
Berridge, C., & Arnsten, A. (2015) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2015.01.002 · Cited by 24
Easton, N., Marshall, F. H., Fone, K. C. F., & Marsden, C. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0756-5 · Cited by 24
Glaser, P. E. A., Thomas, T. C., Joyce, B. M., Castellanos, F. X., & Gerhardt, G. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2012-6 · Cited by 23
Wolf, W. A., Martin, J. W., Kartje, G. L., & Farrer, R. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108031 · Cited by 22
Hensleigh, E., & Pritchard, L. M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.03.045 · Cited by 23
Seminerio, M. J., Kaushal, N., Shaikh, J., Huber, J. D., Coop, A., & Matsumoto, R. R. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.11.023 · Cited by 22
Stanford, S. C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.03.021 · Cited by 22
Amphetamines Improve the Motivation to Invest Effort in Attention-Deficit/Hyperactivity Disorder
Chong, T. T. ‐., Fortunato, E., & Bellgrove, M. A. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0982-23.2023 · Cited by 21
Differential effects of modafinil, methamphetamine, and MDMA on agonistic behavior in male mice
Máchalová, A., Šlais, K., Vršková, D., & Šulcová, A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.04.013 · Cited by 22
Seminerio, M. J., Robson, M. J., McCurdy, C. R., & Matsumoto, R. R. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.07.029 · Cited by 21
Stress Response, Brain Noradrenergic System and Cognition
Winklewski, P. J., Radkowski, M., Wszędybył-Winklewska, M., & Demkow, U. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_204 · Cited by 23
Dopamine Receptor Agonist Treatment of Idiopathic Dystonia: A Reappraisal in Humans and Mice
Fan, X., Donsante, Y., Jinnah, H. A., & Hess, E. J. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.246348 · Cited by 20
Bhimani, R., Vik, M., Wakabayashi, K. T., Szalkowski, C., Bass, C., & Park, J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15470 · Cited by 21
Drug Discrimination in Methamphetamine-Trained Monkeys: Effects of Monoamine Transporter Inhibitors
Czoty, P. W., Ramanathan, C. R., Mutschler, N. H., Makriyannis, A., & Bergman, J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.071035 · Cited by 21
Strackx, E., van den Hove, D., Steinbusch, H. P., Steinbusch, H. W. M., Vles, J. S. H., Blanco, C. E., & Gavilanes, A. W. D. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.02.006 · Cited by 20
Olausson, P., Engel, J. A., & Söderpalm, B. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00228-8 · Cited by 20
Baumann, M. H., PHILLIPS, J. M., AYESTAS, M. A., Ali, S. F., Rice, K. C., & Rothman, R. B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04154.x · Cited by 20
Meth math: modeling temperature responses to methamphetamine
Molkov, Y. I., Zaretskaia, M. V., & Zaretsky, D. V. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00365.2013 · Cited by 21
Fischer, K. D., Houston, A. C. W., Desai, R. I., Doyle, M. R., Bergman, J., Mian, M. N., Mannix, R., Sulzer, D., Choi, S. J., Mosharov, E. V., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4848-1 · Cited by 19
Schouw, M. L. J., Kaag, A. M., Caan, M. W. A., Heijtel, D. F. R., Majoie, C. B. L. M., Nederveen, A. J., Booij, J., & Reneman, L. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2012.12.056 · Cited by 19
Jansen, A. S. P., Schmidt, E. D., Voorn, P., & Tilders, F. J. H. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02453.x · Cited by 19
Baladi, M. G., Newman, A. H., Nielsen, S. M., Hanson, G. R., & Fleckenstein, A. E. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.03.023 · Cited by 18
Lan, K., Ma, T., Lin‐Shiau, S., Liu, S., & Ho, I.-K. (2007) · Journal of Biomedical Science · doi:10.1007/s11373-007-9218-7 · Cited by 18
Sex differences in psychotomimetic-induced behaviours in rats
Gogos, A., Kusljic, S., Thwaites, S. J., & van den Buuse, M. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.01.028 · Cited by 18
Stocco, M. R., El-Sherbeni, A. A., Zhao, B., Novalen, M., & Tyndale, R. F. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05808-9 · Cited by 17
Influences of activity wheel access on the body temperature response to MDMA and methamphetamine
Gilpin, N. W., Wright, M. J., Dickinson, G. D., Vandewater, S. A., Price, J. U., & Taffe, M. A. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.05.006 · Cited by 17
Preece, M., Sibson, N. R., Raley, J. M., Blamire, A. M., Styles, P., & Sharp, T. (2007) · Synapse · doi:10.1002/syn.20442 · Cited by 17
Madden, J. T., Reyna, N. C., & Pentkowski, N. S. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108178 · Cited by 16
Agster, K. L., Clark, B., Gao, W., Shumsky, J. S., Wang, H. X., Berridge, C. W., & Waterhouse, B. D. (2011) · The Anatomical Record · doi:10.1002/ar.21403 · Cited by 16
Effect of risperidone on acute methamphetamine-induced hyperthermia in rats
Shioda, K., Nisijima, K., Yoshino, T., & Kato, S. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.05.001 · Cited by 16
Thioredoxin-1 was Required for CREB Activity by Methamphetamine in Rat Pheochromocytoma Cells
Lv, T., Wang, S., & Bai, J. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9897-0 · Cited by 15
Acute changes in the retina and central retinal artery with methamphetamine
Lee, M., Leskova, W., Eshaq, R. S., & Harris, N. R. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.107964 · Cited by 15
Nishimura, T., Takahata, K., Kosugi, Y., Tanabe, T., & Muraoka, S. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1694-y · Cited by 15
Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions
Kitanaka, J., Kitanaka, N., & Takemura, M. (2006) · Drug Target Insights · doi:10.1177/117739280600100001 · Cited by 15
Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat
Kufahl, P. R., & Olive, M. F. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-003 · Cited by 15
Comparison of some behavioral effects of d- and l-methamphetamine in adult male rats
Siemian, J. N., Xue, Z., Blough, B. E., & Li, J. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4623-8 · Cited by 14
Gelmi, T. J., Verrijken, M., & Weinmann, W. (2020) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2020.104747 · Cited by 14
New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development
Heal, D. J., Gosden, J., & Smith, S. L. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_332 · Cited by 16
Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters
Solis, E. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_39 · Cited by 14
Zhang, X., Wang, Y., Wang, H., Li, H., Zhang, T., Peng, Y., & Wang, X. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b01040 · Cited by 14
Suzuki, T., Shindo, K., Miyatake, M., Kurokawa, K., Higashiyama, K., Suzuki, M., & Narita, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.062 · Cited by 14
Rapid adaptation of torso pointing movements to perturbations of the base of support
Hudson, T. E., Lackner, J. R., & DiZio, P. A. (2005) · Experimental Brain Research · doi:10.1007/s00221-005-2313-y · Cited by 14
Pharmacologic treatment for memory disorder in multiple sclerosis
He, D., Zhou, H., Guo, D., Hao, Z., & Wu, B. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008876.pub2 · Cited by 14
The Role of Serotonin in Drug Addiction
Müller, C. P., Pum, M. E., Schumann, G., & Huston, J. P. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70099-0 · Cited by 13
Hori, Y., Takeda, H., Tsuji, M., & Matsumiya, T. (1998) · Pharmacology · doi:10.1159/000028195 · Cited by 13
Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions.
Kitanaka, J., Kitanaka, N., & Takemura, M. (2006) · Europe PMC (PubMed Central) · Cited by 13
Simultaneous Determination of 11 Illicit Phenethylamines in Hair by LC–MS-MS:In VivoApplication
Nieddu, M., Burrai, L., Demontis, M. P., Varoni, M. V., Baralla, E., Trignano, C., & Boatto, G. (2015) · Journal of Analytical Toxicology · doi:10.1093/jat/bkv054 · Cited by 12
Ranaldi, R., Anderson, K. G., Carroll, F. I., & Woolverton, W. L. (2000) · Psychopharmacology · doi:10.1007/s002130000602 · Cited by 12
Yin, H.-S., Lai, C.-C., Tien, T.-W., Han, S.-K., & Pu, X.-L. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.06.007 · Cited by 11
Kassim, F. M. (2023) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2856 · Cited by 11
“their release through a reversal of the monoamine transporters, primarily the catecholamine transporters (see Fleckenstein et al., 2007; Hutson et al., 2014, for review; Kuczenski et al., 1995; Sulzer et al., 2005).”
BackgroundNishino, S. (2008) · Springer eBooks · doi:10.1007/978-1-4419-0854-4_24 · Cited by 11
Speiser, Z., Fine, T., Litinetsky, L., Eliash, S., Blaugrund, E., & Cohen, S. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0811-8 · Cited by 11
Neurochemical and behavioural characterisation of alkoxyamphetamine derivatives in rats
Romero, C. A., Bustamante, D. A., Zapata‐Torres, G., Goiny, M., Cassels, B. K., & Herrera‐Marschitz, M. (2006) · Neurotoxicity Research · doi:10.1007/bf03033330 · Cited by 11
Recovery of Neurological Function
Chollet, F., & Weiller, C. (2000) · Elsevier eBooks · doi:10.1016/b978-012481460-8/50027-5 · Cited by 11
Hamilton, W. R., Trickler, W. J., Robinson, B. L., Paule, M. G., & Ali, S. F. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.02.085 · Cited by 10
Toxic Effect of Methamphetamine on the Retina of CD1 Mice
Lai, H. C., Zeng, H., Zhang, C., Wang, L., Tso, M. O. M., & Lai, S. (2009) · Current Eye Research · doi:10.1080/02713680903079641 · Cited by 10
Amphetamine's dose-dependent effects on dorsolateral striatum sensorimotor neuron firing
Ma, S., Pawlak, A. P., Cho, J., Root, D. H., Barker, D. J., & West, M. O. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.044 · Cited by 10
MASUBUCHI, S., Honma, S., Hiroshi, A. B. E., Namihira, M., & Honma, K. (2007) · Sleep and Biological Rhythms · doi:10.1111/j.1479-8425.2007.00263.x · Cited by 10
Cassaday, H. J., Finger, B., & Horsley, R. R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107083842 · Cited by 10
Effects of l-methamphetamine treatment on cocaine- and food-maintained behavior in rhesus monkeys
Kohut, S. J., Bergman, J., & Blough, B. E. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4186-5 · Cited by 10
Domínguez-López, S., Ahn, B., Sataranatarajan, K., Ranjit, R., Premkumar, P., Remmen, H. V., & Beckstead, M. J. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109436 · Cited by 9
Kitanaka, N., Kitanaka, J., Hall, F. S., Kayama, M., Sugimori, H., Uhl, G. R., & Takemura, M. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s27733 · Cited by 9
Discriminative Stimulus Effects of Psychostimulants
Berquist, M. D., & Fantegrossi, W. E. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_5 · Cited by 9
Low-normal doses of methiopropamine induce aggressive behaviour in mice
Foti, F., Bilel, S., Tirri, M., Arfè, R., Boccuto, F., Bernardi, T., Serpelloni, G., De‐Giorgio, F., & Marti, M. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05813-y · Cited by 9
Ferrucci, M., Busceti, C. L., Nori, S. L., Lazzeri, G., Bovolin, P., Falleni, A., Mastroiacovo, F., Pompili, E., Fumagalli, L., Paparelli, A., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.07.057 · Cited by 9
The Actions of NO in the Central Nervous System and in Thymocytes
Murayama, T., & Nomura, Y. (1998) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.76.129 · Cited by 9
Effects of amphetamine on serotoninergic and GABAergic expression of developing brain
Yin, H., & Tan, H.-W. (2006) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2006.10.001 · Cited by 9
Overview of Management of Narcolepsy
Nishino, S., & Kotorii, N. (2008) · Springer eBooks · doi:10.1007/978-1-4419-0854-4_23 · Cited by 8
Pauly, R. C., Bhimani, R. V., Li, J., Blough, B. E., Landavazo, A., & Park, J. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00689 · Cited by 8
Elder, H., Walentiny, D. M., & Beardsley, P. M. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173735 · Cited by 8
Non-coding RNA: insights into the mechanism of methamphetamine neurotoxicity
Gu, Y., Chen, L., Cheng, L., Zhou, M., & Wang, Y. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04160-y · Cited by 8
The role of serotoninergic system in psychostimulant effects
Taracha, E. (2021) · Postępy Psychiatrii i Neurologii · doi:10.5114/ppn.2021.111939 · Cited by 8
Armstrong, V., Nazarian, A., Zavala, A. R., Krall, C. M., Crawford, C. A., & McDougall, S. A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00607-4 · Cited by 8
Neurochemical and Neurobehavioral Consequences of Methamphetamine Abuse
Haile, C. N. (2007) · CRC Press eBooks · doi:10.1201/9781420054422.ch4 · Cited by 8
Kohut, S. J., Jacobs, D. S., Rothman, R. B., Partilla, J. S., Bergman, J., & Blough, B. E. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4731-5 · Cited by 8
Yu, M., Fu, W., & Yin, H. (2000) · Journal of Molecular Neuroscience · doi:10.1385/jmn:15:3:177 · Cited by 8
Tin-Tin-Win-Shwe, T., Mitsushima, D., & Kimura, F. (2002) · Neuroendocrinology · doi:10.1159/000066625 · Cited by 8
Webster, J., Harper, D. N., & Schenk, S. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000282 · Cited by 7
Rewarding and Reinforcing Effects of 25H-NBOMe in Rodents
Jo, C., Joo, H., Youn, D., Kim, J. M., Hong, Y., Lim, N. Y., Kim, K. S., Park, S., & Choi, S. O. (2022) · Brain Sciences · doi:10.3390/brainsci12111490 · Cited by 7
A Sympathetic Treatment for Obesity
Kim, J. D., & Diano, S. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.009 · Cited by 7
Bundgaard, C., Montezinho, L. P., Anderson, N., Thomsen, C., & Mørk, A. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.10.003 · Cited by 7
Zhao, C., Lou, Z., Zimmer, B., Yu, Z., Li, P., Ma, B., Sun, Y., Huang, K., Zhou, W., & Liu, Y. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.06.011 · Cited by 7
Solomon, M. B., Yegla, B., Newcorn, J. H., Maletic, V., Rubin, J. S., & Robbins, T. W. (2025) · Clinical Drug Investigation · doi:10.1007/s40261-025-01473-4 · Cited by 9
Screening Method for Five Commonly Used Amphetamines in Urine by NMR Spectroscopy
Nieddu, M., Carta, A., Burrai, L., Porcu, M. C., Culeddu, N., Pirisi, M. A., & Boatto, G. (2014) · Applied Magnetic Resonance · doi:10.1007/s00723-013-0507-1 · Cited by 6
Kusljic, S., van den Buuse, M., & Gogos, A. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2101017 · Cited by 6
Ottonelli, I., Sharma, A., Ruozi, B., Tosi, G., Duskey, J. T., Vandelli, M. A., Lafuente, J. V., Nozari, A., Muresanu, D. F., Buzoianu, A. D., et al. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-32997-5_10 · Cited by 7
Saber, I., Milewski, A., Reitz, A. B., Rawls, S. M., & Walker, E. A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05241-z · Cited by 6
Win‐Shwe, T., Mitsushima, D., Yamamoto, S., Funabashi, T., & Fujimaki, H. (2009) · NeuroImmunoModulation · doi:10.1159/000204232 · Cited by 6
Niimi, K., & Takahashi, E. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.04.042 · Cited by 7
Yu, M., Chien, C. L., Lee, W., & Yin, H. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:25:2:171 · Cited by 6
Neurodegeneration from Drugs and Aging‐Derived Free Radicals
Ramkissoon, A., Shapiro, A. M., Loniewska, M. M., & Wells, P. G. (2013) · Wiley eBooks · doi:10.1002/9781118355886.ch10 · Cited by 6
Macaskill, A. C., Harrow, C. C., & Harper, D. N. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.11.009 · Cited by 5
Pseudomonas Persists by Feeding off Itaconate
Runtsch, M. C., & O'Neill, L. A. J. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.005 · Cited by 5
Xue, Z., Siemian, J. N., Zhu, Q., Blough, B. E., & Li, J. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000453 · Cited by 5
Schoenberg, H. L., Evans, C., Bausch, L., Wootton, A., Kirshenbaum, A. P., & Toufexis, D. J. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113636 · Cited by 4
Nishino, S., & Kotorii, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-23739-8_22 · Cited by 6
Metadata
- Authors
- Kuczenski, R., Segal, D., Cho, A., & Melega, W.
- Affiliations
- UC San Diego Health System (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1995-02-01
- Volume
- 15
- Issue
- 2
- Pages
- 1308-1317
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6577819
- OpenAlex
- W1934404972
- Cited by
- 376
- References
- 44
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 11 · 2022: 10 · 2021: 13 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 11 · 2016: 9 · 2015: 9 · 2014: 24 · 2013: 18 · 2012: 22
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01da002411-13, 5r01da004157-14)
- U.S. Public Health Service
- National Institute on Drug Abuse (DA-01568, DA 02411, DA04157, R01DA001568)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- methamphetamine, d-amphetamine, stereotypy, dopamine release, noradrenaline release, serotonin release, caudate nucleus, hippocampus, vesicular transporters, structure-activity relationship, microdialysis
- MeSH terms
- Amphetamine, Animals, Behavior, Animal, Caudate Nucleus, Dopamine, Hippocampus, Methamphetamine, Norepinephrine, Serotonin, Stereoisomerism, Stereotyped Behavior, Microdialysis, Neurotransmitter Agents, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review